Clinical Trial Update: [18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

The document reports results from an early Phase 1 trial evaluating the [18F]F-AraG total-body PET imaging agent in healthy subjects and patients with non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• [18F]F-AraG

Snippet

Sponsor: University of California, Davis | Conditions: Lung Cancer, Nonsmall Cell | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-07-02